Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

ICU TopicsRespiratory / ventilation

ICU · Respiratory / ventilation

Acute Severe Ventilation Weaning and Liberation from Mechanical Ventilation — Comprehensive ICU Management

Also known as Ventilator weaning · Liberation from mechanical ventilation · Spontaneous breathing trial · SBT · ABC trial · Wake up and breathe · Rapid shallow breathing index · Cuff leak test · Post-extubation stridor · ICU-acquired weakness · Weaning-induced pulmonary oedema · Difficult weaning · Protocol-directed weaning

Weaning (liberation) from mechanical ventilation is the graded withdrawal of ventilatory support once the precipitating cause of respiratory failure has resolved. Readiness is assessed daily against objective criteria — resolution of the cause, FiO2 <0.4, PEEP <8 cmH2O, haemodynamic stability, adequate cough and gag, manageable secretions, and an awake, triggering patient — followed by a spontaneous breathing trial (SBT) delivered as pressure support 5-7 cmH2O with PEEP 5, or a T-piece, for 30-120 minutes. The patient passes if respiratory rate is <35, SpO2 >90 per cent, heart rate <140, with no agitation, diaphoresis, or distress. The ABC trial (Girard, Lancet 2008) proved that pairing a daily spontaneous awakening trial (SAT, daily sedation interruption) with a daily SBT — the 'wake up and breathe' protocol — shortens ventilation time and ICU stay and saves one life for every seven patients treated. Protocol-directed (nurse or respiratory-therapist driven) weaning outperforms physician-directed weaning. Weaning is classified as simple, difficult (more than three SBT attempts or more than seven days), or prolonged (more than fourteen days); difficult and prolonged weaning demands a systematic hunt for the cause — cardiac (weaning-induced pulmonary oedema from left ventricular dysfunction unmasked by the switch to negative-pressure breathing), respiratory-muscle weakness (ICU-acquired weakness), residual respiratory load (auto-PEEP, secretions), electrolyte derangement, or delirium and agitation. The cuff leak test (leak <110 mL or <24 per cent of tidal volume) and laryngeal ultrasound identify patients at high risk of post-extubation stridor, who benefit from prophylactic steroids. Prophylactic non-invasive ventilation (NIV) immediately after extubation prevents reintubation in high-risk patients (COPD, hypercapnia, cardiac failure); NIV used as rescue after established extubation failure is harmful. Tracheostomy facilitates prolonged weaning, but the TracMan trial (Young, JAMA 2013) showed no mortality benefit to early (day 4) over late (day 10) placement.

high6 referencesUpdated 2 July 2026
On this page & tools

Your progress

Saved locally on this device.

Practise this topic

4 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

Weaning is attempted only after the precipitating cause of respiratory failure has reversed — daily screening for readiness, not a fixed calendar dateA failing spontaneous breathing trial must be terminated and support restored immediately — never push a patient through distress (tachypnoea, desaturation, agitation, diaphoresis)Cardiac failure is the commonest occult cause of difficult weaning — the switch from positive to negative-pressure breathing increases venous return and left-ventricular afterload, unmasking occult LV dysfunction (weaning-induced pulmonary oedema)A cuff leak &lt;110 mL predicts post-extubation stridor — perform a cuff leak test in high-risk patients and give prophylactic steroidsNIV prevents reintubation when applied immediately after extubation in high-risk patients, but NIV as rescue after established extubation failure increases mortality — do not delay reintubationRoutine early tracheostomy (TracMan) does not improve mortality — time it to the individual patient, usually after 7-14 days if prolonged ventilation is anticipated

Your progress

Saved locally on this device.

Practise this topic

4 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

Weaning is attempted only after the precipitating cause of respiratory failure has reversed — daily screening for readiness, not a fixed calendar dateA failing spontaneous breathing trial must be terminated and support restored immediately — never push a patient through distress (tachypnoea, desaturation, agitation, diaphoresis)Cardiac failure is the commonest occult cause of difficult weaning — the switch from positive to negative-pressure breathing increases venous return and left-ventricular afterload, unmasking occult LV dysfunction (weaning-induced pulmonary oedema)A cuff leak &lt;110 mL predicts post-extubation stridor — perform a cuff leak test in high-risk patients and give prophylactic steroidsNIV prevents reintubation when applied immediately after extubation in high-risk patients, but NIV as rescue after established extubation failure increases mortality — do not delay reintubationRoutine early tracheostomy (TracMan) does not improve mortality — time it to the individual patient, usually after 7-14 days if prolonged ventilation is anticipated

In one line

Liberation from mechanical ventilation is a daily, protocolised process: screen every patient for readiness (cause resolved, FiO2 <0.4, PEEP <8 cmH2O, haemodynamically stable, minimal secretions, cough and gag intact, awake and triggering); if ready, perform a spontaneous breathing trial (SBT) — pressure support 5-7 cmH2O + PEEP 5 or a T-piece for 30-120 minutes; pass if RR <35, SpO2 >90 per cent, HR <140, with no agitation, diaphoresis, or distress. Pair every SBT with a daily spontaneous awakening trial (SAT) — the ABC trial (Girard, Lancet 2008) proved "wake up and breathe" cuts ventilation days, ICU stay, and mortality (one life saved per seven treated).[1] Use protocol-directed (nurse or RT-driven) weaning, which outperforms physician-directed weaning.[2][3] Weaning is simple (success on first attempt), difficult (up to three SBT attempts or up to seven days), or prolonged (more than seven days or three failed SBTs).[2] Difficult or prolonged weaning triggers a systematic cause hunt: cardiac (weaning-induced pulmonary oedema), respiratory-muscle weakness (ICU-acquired weakness), residual load, electrolyte derangement, delirium. Before extubation, perform a cuff leak test (leak <110 mL predicts post-extubation stridor) and give prophylactic steroids if positive. Apply prophylactic NIV immediately after extubation in high-risk patients (COPD, hypercapnia, cardiac failure) — but never use NIV as rescue for established extubation failure.[5] For prolonged weaning, a tracheostomy aids liberation, but early tracheostomy does not improve mortality (TracMan, JAMA 2013).[6]

Cinematic ICU scene of an intubated patient undergoing a spontaneous breathing trial on pressure support 5 with PEEP 5, the ventilator screen showing spontaneous triggered breaths, the nurse at the bedside monitoring respiratory rate and tidal volume, a low-dose sedation infusion, a cuff leak test syringe on the trolley, a respiratory therapist reviewing the weaning protocol checklist on a tablet, warm clinical lighting with focused teal accents
FigureLiberation from the ventilator — daily readiness screen, a paired SAT and SBT, and a protocol-driven pathway. Pass the trial, extubate; fail the trial, restore support and hunt the cause.

What weaning actually means

Weaning (more accurately termed liberation or discontinuation) is the graded process of withdrawing ventilatory support once the precipitating cause of respiratory failure has resolved. It is emphatically not the abrupt removal of the tube. Two conceptually separate decisions sit inside the word "weaning": [1]

  1. Separation from the ventilator — the progressive reduction of mechanical support (via a spontaneous breathing trial) until the patient can sustain unassisted breathing through the endotracheal tube.
  2. Extubation — the removal of the artificial airway once the patient can protect their airway, clear secretions, and breathe unassisted. [1]

A patient may pass a breathing trial but still fail extubation because of upper-airway obstruction (post-extubation stridor), inadequate cough, or impaired consciousness. Conversely, a patient with a tracheostomy can be separated from the ventilator without any extubation event. The fellowship-level point is that these are two distinct assessments and conflating them is a common source of error. [1]

The international consensus conference of the ERS, ATS, ESICM, SCCM, and SRLF (the Boles consensus, 2007) framed weaning around the balance between respiratory load and neuromuscular capacity: liberation succeeds when capacity exceeds load, and fails when load outstrips capacity (because of unresolved disease, increased load, reduced capacity, or an excessive psychological/medication burden). Every step of the weaning pathway — the readiness screen, the breathing trial, the extubation check, and the investigation of failure — is an interrogation of that balance. [1]

The three categories — simple, difficult, and prolonged weaning

Weaning categories simple difficult prolonged with readiness screen and SBT pass-fail criteria on a clinical blue infographic
FigureSimple, difficult and prolonged weaning — classify by SBT attempts and calendar days, then hunt reversible causes when liberation stalls.

Not every liberation is straightforward. The Boles consensus stratified weaning into three groups by how quickly the patient separates from the ventilator, and this classification predicts outcome and directs the intensity of the workup: [1]

Weaning categories (click each)

~10% of patients

Mortality high

More than three failed SBTs, or more than seven days (often framed as beyond 14 days) of weaning effort. Accounts for about 10 per cent. Carries the highest mortality and resource use; consider tracheostomy, rehabilitation, and a structured prolonged-weaning programme.

A second framework — the WIND (Weaning according to a New Definition) classification — groups patients by the number of days from separation attempt to successful extubation, but the Boles categories remain the exam-friendly and clinically intuitive standard. The key message: difficult and prolonged weaning are not failures of technique but signals of an unaddressed problem that must be diagnosed and treated. [1]

Assessing readiness — the daily screen

The single most important weaning intervention is the daily screen for readiness, because the patient who is ready but not tested stays on the ventilator longer than necessary — accumulating sedation, weakness, and infection. Every intubated patient should be screened at least once a day (usually on the morning ward round) once the precipitating insult is improving.[1][4]

Cause resolved

The precondition

  • The precipitating cause of respiratory failure (sepsis, pneumonia, pulmonary oedema, COPD exacerbation) is reversing
  • There is no new, untreated problem driving ventilatory demand
  • Without this, weaning is premature regardless of the numbers

Oxygenation

FiO2 and PEEP

  • FiO2 <0.4 (40 per cent) — able to oxygenate on near-ambient oxygen
  • PEEP <5-8 cmH2O
  • PaO2/FiO2 >150-200 mmHg
  • No escalating oxygen requirement

Respiratory drive

Triggering

  • Patient triggers spontaneous breaths (no full mandatory control)
  • Adequate cough and gag reflexes (airway protection)
  • Minimal or manageable secretions

Stability

Circulation and brain

  • Haemodynamically stable — no or low-dose vasopressors, no active myocardial ischaemia, no uncontrolled arrhythmia
  • Awake and cooperative or easily arousable — minimal sedation (ideally a daily SAT has been passed)
  • No significant metabolic acidosis; acceptable electrolytes (K+, Mg2+, PO4^3-)
  • Afebrile or settling; adequate haemoglobin

The readiness screen is binary and daily

A patient either meets the readiness criteria or does not — there is no value in a "nearly ready" designation that postpones the test. The purpose of the daily screen is to find every eligible patient and test them with an SBT the same day. Patients who are tested earlier are extubated earlier. The screen is the rate-limiting step, not the trial itself.[1]

The spontaneous breathing trial (SBT)

Once a patient passes the readiness screen, the next step is the spontaneous breathing trial (SBT) — a period of breathing with little or no ventilatory support, conducted through the endotracheal tube, to determine whether the patient can sustain unassisted ventilation. The SBT is the cornerstone of the liberation decision: a patient who passes an SBT has roughly an 80 per cent chance of successful extubation.[3]

Conducting an SBT — the pathway

1

Confirm readiness and safety

Confirm the patient passed the daily readiness screen and meets SBT safety criteria: no active myocardial ischaemia, no significant vasopressor escalation, no copious secretions requiring frequent suctioning, SpO2 acceptable on FiO2 <0.4. Do not run an SBT in an unstable patient.

2

Choose the modality and set support

Two equivalent options: (a) low level of pressure support — PS 5-7 cmH2O with PEEP 5 cmH2O; or (b) T-piece (zero ventilatory support, humidified oxygen). Pressure support offsets the resistive work of the endotracheal tube; the T-piece is a purer test of capacity. A brief (5 min) low-PS "warm-up" before a T-piece is sometimes used. Both modalities give equivalent extubation outcomes.

3

Run for 30-120 minutes

Duration is typically 30 minutes (a 30-minute trial is as predictive as a 120-minute trial). Observe continuously. A 120-minute trial is reasonable in higher-risk patients or when cardiac failure is suspected.

4

Monitor pass/fail criteria in real time

Watch for failure signs throughout: RR rising toward 35, SpO2 falling below 90 per cent, HR rising above 140 or new arrhythmia, agitation, anxiety, diaphoresis, accessory-muscle use, altered mental status, or a falling tidal volume (shallow breathing).

5

If the patient PASSES

RR <35, SpO2 >90 per cent, HR <140, no agitation/diaphoresis/distress, stable haemodynamics, adequate tidal volume — proceed to extubation assessment (cough, secretions, cuff leak if high-risk, mental status) and extubate.

6

If the patient FAILS

Terminate the trial at once and restore comfortable ventilatory support. Do not push through distress. Document WHY it failed (respiratory vs cardiac vs neurological) and hunt the cause. Re-attempt daily only when the reversible cause has been addressed.

SBT pass and fail criteria — the numbers to know

SBT — pass criteria (all must hold)

<35
Respiratory rate (/min)
sustained
>90%
SpO2
on FiO2 <0.4
<140
Heart rate (/min)
no new arrhythmia
<180/90
SBP/DBP (mmHg)
stable haemodynamics

SBT — fail criteria (any one mandates stopping)

≥35
RR (/min)
tachypnoea
≤90%
SpO2
or falling
≥140
HR (/min)
or >20% rise
distress
Agitation / diaphoresis / AMS
stop and restore support

A failing SBT is terminated — never prolonged

The SBT is a test, not a treatment. The instant the patient develops tachypnoea, desaturation, agitation, diaphoresis, or haemodynamic instability, stop the trial and restore comfortable support. Pushing a patient through a failing trial causes fatigue, worsens gas exchange, and may precipitate cardiac ischaemia or respiratory arrest. The information gained (that the patient is not yet ready) is the entire point — act on it.[3]

The "wake up and breathe" protocol — pairing the SAT with the SBT (ABC trial)

The most influential advance in ventilator liberation was the recognition that sedation and weaning are inseparable: a patient cannot breathe spontaneously while deeply sedated, and accumulated sedation is one of the commonest reasons for delayed liberation. The solution is to pair a daily spontaneous awakening trial (SAT, the daily sedation interruption) with a daily SBT — the "wake up and breathe" protocol. [1]

The ABC 'wake up and breathe' protocol

1

Step 1 — SAT safety screen

Before stopping sedation, confirm the patient is safe to wake: no active seizures, no agitation, no myocardial ischaemia, no high intracranial pressure, not paralysed, on acceptable oxygenation and PEEP, no escalating vasopressors.

2

Step 2 — Spontaneous awakening trial (SAT)

Stop all sedatives and opioids (or reduce to the lightest level). Observe. If the patient becomes agitated, in pain, or unstable, restart sedation at half the previous dose — a "failed SAT." If the patient opens eyes, follows commands, or is calmly awake, the SAT is passed.

3

Step 3 — SBT readiness screen

With the patient now awake, apply the standard readiness criteria (cause resolved, FiO2 <0.4, PEEP <8, stable, triggering, cough/gag intact).

4

Step 4 — Spontaneous breathing trial (SBT)

Run a 30-120 minute SBT on PS 5-7 + PEEP 5 or a T-piece. Assess pass/fail criteria continuously.

5

Step 5 — Extubation decision

If the SBT is passed, assess for extubation (airway protection, secretions, cuff leak if high-risk) and extubate. If the SBT fails, restore comfortable support, restart sedation at a reduced dose, and repeat the whole cycle the next day.

The Awakening and Breathing Controlled (ABC) trial (Girard et al., Lancet 2008) randomised 336 mechanically ventilated patients to either a paired daily SAT + SBT ("wake up and breathe") or usual sedation plus a daily SBT.[1] The intervention group spent more days breathing without assistance (14.7 vs 11.6 days), had shorter ICU stay (median 9.1 vs 12.9 days) and hospital stay, and — strikingly — had lower one-year mortality (HR 0.68). The number needed to treat to save one life was 7. Although self-extubation was more common in the intervention arm, reintubation rates were identical. The take-home: pairing awakening with breathing is the standard of care.

The earlier evidence for the SAT component alone came from Kress et al. (NEJM 2000), who showed that daily interruption of sedative infusions reduced the duration of mechanical ventilation (median 4.9 vs 7.3 days) and ICU length of stay (6.4 vs 9.9 days) without an excess of complications.[4] Together, these trials form the evidence base for the ABCDEF bundle of the modern PADIS (Pain, Agitation/Sedation, Delirium, Immobility, Sleep) guidelines: Assess pain, Both SAT and SBT, Choice of analgesia and sedation, Delirium monitoring, Early mobility, Family engagement.

SBT technique — pressure support versus T-piece

The SBT can be delivered as a low level of pressure support (PS 5-7 cmH2O with PEEP 5 cmH2O) or as a T-piece (the patient breathes spontaneously through the endotracheal tube connected to humidified oxygen, with no ventilatory support). A third, less common option is CPAP alone (continuous positive airway pressure without inspiratory support). [1]

Pressure support (PS 5-7 + PEEP 5)

Most common first-line SBT

  • Offset the resistive work of breathing through the endotracheal tube
  • PS 5-7 with PEEP 5 is the standard "minimal support" SBT
  • Generally better tolerated; the ventilator still monitors volumes and apnoea
  • Slight overestimate of capacity — the tube adds resistance that will be removed at extubation

T-piece

Purer test of capacity

  • Zero pressure support — the patient does all the work against the tube
  • A more stringent test; some clinicians prefer it in suspected cardiac failure (no positive-pressure support to mask LV dysfunction)
  • No apnoea backup or ventilator alarms — closer bedside observation required
  • Consider after a brief low-PS warm-up to avoid abrupt load

30 vs 120 minutes

Duration

  • A 30-minute SBT is as predictive of extubation success as a 120-minute trial (Esteban 1997)
  • Use 30 minutes for routine first-time weaning
  • Consider 120 minutes (or longer) in high-risk patients, suspected cardiac failure, or prolonged ventilation
  • Cardiac failure may declare itself only after 30-60 min of negative-pressure breathing

Pressure support and T-piece SBTs give equivalent extubation outcomes

Randomised comparisons (Esteban et al., 1997 and 1999) found no difference in the rate of reintubation between patients whose SBT used a T-piece versus pressure support. Either is acceptable. In practice, pressure support 5-7 + PEEP 5 is the workhorse, with a T-piece reserved for patients in whom a more stringent test is wanted or when cardiac failure is suspected (the T-piece removes the positive-pressure crutch that can mask early pulmonary oedema).

[1]

Protocol-directed versus physician-directed weaning

How the weaning pathway is executed matters as much as the physiology. Two landmark trials established that weaning driven by a protocol executed by nurses and respiratory therapists is faster than weaning directed at the discretion of the physician. [1]

In Brochard et al. (AJRCCM 1994), 456 ventilated patients who met weaning criteria were screened; 109 who failed a two-hour T-piece trial were randomised to weaning by pressure support, SIMV, or T-piece trials.[2] Pressure support was superior: fewer weaning failures (23 per cent PS vs 43 per cent T-piece vs 42 per cent SIMV) and a shorter weaning duration (mean 5.7 days for PS vs 8.5 days T-piece vs 9.9 days SIMV). This trial also established the framework for categorising weaning difficulty.

In Esteban et al. (NEJM 1995), 130 patients who failed an initial two-hour breathing trial were randomised among four techniques: IMV, pressure support, intermittent (multiple daily) SBTs, or a once-daily SBT.[3] The once-daily SBT weaned patients about three times faster than IMV (rate ratio 2.83) and about twice as fast as pressure support (rate ratio 2.05), with multiple daily SBTs equally successful. The message: a daily trial of spontaneous breathing is the most effective weaning method for the patient who has not yet separated.

Weaning method — what the trials showed

5.7 d
PSV wean duration
Brochard 1994 — shortest
2.83
SBT vs IMV rate ratio
Esteban 1995 — daily SBT wins
3.1 d
More ventilator-free days
ABC trial, paired SAT+SBT
NNT 7
Lives saved
ABC trial one-year mortality

Complementary evidence (Ely et al., 1996) showed that a nurse/RT-driven protocol — in which bedside staff conduct the daily screen and SBT without waiting for a physician order — reduced the duration of mechanical ventilation compared with physician-directed weaning. The mechanism is simple: protocols remove the variability and delay of physician decision-making and ensure every eligible patient is tested every day. Protocol-directed weaning is the standard of care. [1]

Protocols beat physician discretion

The evidence is consistent: a standardised, nurse or respiratory-therapist-driven protocol that screens for readiness daily and performs an SBT the same day shortens ventilation compared with ad-hoc physician-directed weaning. The win comes from consistency and timing, not from any single ventilator setting. A protocol also strips emotion and inertia from the decision to test.[2][3]

Indices that predict weaning success — the RSBI and beyond

A battery of physiological indices has been proposed to predict weaning outcome. In practice, the SBT itself is the best predictor, but the indices are useful for the difficult or prolonged weaning patient and are frequent exam fodder. [1]

RSBI (f/Vt)

Rapid shallow breathing index

  • RSBI = respiratory rate ÷ tidal volume (in litres), measured during unassisted breathing
  • Threshold <105 predicts success; >105 predicts failure (Yang and Tobin, 1991)
  • The single most validated weaning index, but imperfect (sensitivity and specificity each ~80%)
  • Measured on PS 0 / PEEP 0 (or minimal support) for one minute

P0.1

Airway occlusion pressure

  • Negative pressure generated against an occluded airway 0.1 s after inspiration begins — an index of respiratory drive
  • Normal ~2-4 cmH2O; values >4-6 suggest high drive / impending fatigue
  • Useful in the difficult weaning patient to distinguish fatigue from central depression

Maximal inspiratory pressure (MIP / NIF)

Muscle strength

  • Maximum negative pressure generated against an occluded airway
  • Threshold more negative than -20 to -30 cmH2O generally supports weaning
  • Effort-dependent; low specificity but useful to flag severe weakness (e.g. ICU-AW, neuromuscular disease)

Others

Adjunctive clues

  • Static compliance, dynamic compliance, work of breathing
  • Gastric tonometry / regional CO2 (research)
  • Bedside ultrasound (diaphragm thickening fraction, lung B-lines for occult oedema)
  • None replaces the SBT; use them to dissect the cause of difficult weaning

The SBT beats every predictive index

No single index — not the RSBI, P0.1, nor the MIP — outperforms the SBT itself as the predictor of extubation success. The indices are best used as diagnostic tools in the difficult-weaning patient: the RSBI to quantify load, P0.1 to assess drive, the MIP to assess strength, and ultrasound to look for cardiac failure or diaphragm dysfunction. Do not let a "good" number talk you into extubating a patient who looks distressed, nor a "bad" number prevent you from testing a patient who looks ready.[3]

Extubation — deciding to remove the tube

Passing the SBT means the patient can probably breathe without the ventilator; the next, separate question is whether they can manage without the endotracheal tube. Extubation assessment covers three domains the SBT does not test: [1]

The extubation assessment

1

Airway protection

Is the patient awake enough to protect the airway? Assess level of consciousness (obeys commands, GCS adequate), cough strength (can the patient cough against a closed tube?), and gag reflex. A weak cough or obtunded patient is at high risk of aspiration and secretion encumbrance after extubation.

2

Secretion load

Are secretions manageable? Quantify the volume and frequency of suctioning. Copious or thick secretions, or a patient who cannot clear them, predicts post-extubation failure. Sputum characteristics and the suction frequency over the preceding 24 h guide this.

3

Upper-airway patency (cuff leak)

Is there room for airflow around the tube once the cuff is down and the tube is removed? In patients at high risk of laryngeal oedema (prolonged intubation, traumatic intubation, female, large tube, repeated intubation, cuff over-inflation), perform a cuff leak test. A reduced leak predicts post-extubation stridor.

4

Decision

If the SBT was passed and the airway, secretions, and cuff leak are acceptable, extubate. If any domain fails, address it (e.g. steroids for a positive cuff leak; treat secretions; lighten sedation and re-test) before extubation.

The cuff leak test and post-extubation stridor

Post-extubation stridor (PES) — upper-airway obstruction from laryngeal oedema after tube removal — occurs in roughly 2-16 per cent of extubations and carries a high reintubation rate and mortality. The cuff leak test identifies patients at risk before the tube comes out, so prophylactic steroids can be given. [1]

The cuff leak test — how to do it and what it means

With the patient ventilated in an assisted mode (set tidal volume constant), deflate the cuff and record the difference between the delivered (set) tidal volume and the exhaled (returned) tidal volume — the leak around the tube. A leak <110 mL, or <24 per cent of the delivered tidal volume, predicts post-extubation stridor. (An alternative method uses the difference in expired volume before and after cuff deflation.) A positive (small) leak warrants prophylactic steroids (e.g. methylprednisolone 20-40 mg IV every 4-6 h, or dexamethasone, started 12-24 h before planned extubation and continued for 24-48 h), which reduce the incidence and severity of PES and the need for reintubation.

[1]

Laryngeal (air-column) ultrasound is a newer adjunct: the air-column width (the echo from airflow around the tube) measured before and after cuff deflation, and the change in air-column width ratio, predict PES — a small increase or a low ratio flags laryngeal oedema. Laryngeal ultrasound is non-invasive and increasingly used at the bedside, though the cuff leak test remains the established standard. [1]

Who to test

High-risk patients

  • Prolonged intubation (>6 days, especially >5-7 days)
  • Traumatic or repeated intubation; tight-fitting or oversized tube
  • Female sex, low body mass index
  • High cuff pressures, head/neck surgery, laryngeal trauma

If positive (small leak)

Give steroids

  • Methylprednisolone 20-40 mg IV q4-6h or dexamethasone, starting 12-24 h before extubation
  • Steroids reduce laryngeal oedema, PES, and reintubation (multiple trials confirm benefit)
  • Extubate in a controlled setting with a plan for immediate reintubation if stridor develops
  • Racemic adrenaline and helium-oxygen may help established mild stridor but are not a substitute for reintubation in severe obstruction
[1]

Non-invasive ventilation to prevent extubation failure

NIV has two distinct, opposite roles around extubation, and confusing them is dangerous: [1]

Prophylactic NIV (preventive)

Apply immediately after extubation in high-risk patients — GOOD

  • Given immediately after extubation to patients predicted to fail, before any respiratory distress develops
  • Reduces reintubation and mortality in high-risk groups: COPD, hypercapnia during the SBT, cardiac failure, older age, obesity, multiple comorbidities
  • Ferrer 2003: in COPD patients with persistent weaning failure, extubating to NIV shortened ventilation, reduced nosocomial pneumonia, and improved survival vs continued invasive weaning
  • The benefit comes from avoiding re-exposure to the complications of invasive ventilation (VAP, sedation, weakness)

Rescue NIV (therapeutic)

Applied after established post-extubation respiratory failure — HARMFUL

  • Started after the patient has already developed respiratory distress post-extubation
  • Esteban 2004 showed this strategy INCREASED mortality (likely by delaying necessary reintubation)
  • Do not use NIV to "rescue" an extubated patient who is failing — reintubate promptly
  • The window for NIV is before failure, not after

The Ferrer trial (AJRCCM 2003) is the key weaning-NIV reference: in 43 patients (predominantly COPD) who had failed weaning for three consecutive days, immediate extubation to NIV versus continued invasive weaning gave shorter invasive ventilation (9.5 vs 20.1 days), shorter ICU stay, less nosocomial pneumonia (24 vs 59 per cent), fewer tracheostomies, and improved survival.[5] The lesson: in the COPD or hypercapnic patient stuck on the ventilator, extubate to NIV rather than persisting with invasive weaning.

NIV: prophylactic good, rescue bad

Prophylactic NIV — applied immediately after extubation to a high-risk patient (COPD, hypercapnia on the SBT, cardiac failure, older, obese) — reduces reintubation and mortality. Rescue NIV — started after a patient has already failed extubation — increases mortality by delaying reintubation. The distinction is timing: use NIV to prevent failure, never to treat it.[5]

Difficult and prolonged weaning — the systematic cause hunt

Difficult weaning cause map: cardiac pulmonary oedema, ICU-acquired weakness, residual load secretions auto-PEEP, electrolytes, delirium; cuff leak and prophylactic NIV pathway
FigureFailed or repeated SBT — cardiac, neuromuscular, load, metabolic and delirium axes; cuff leak and prophylactic NIV protect high-risk extubations.

When a patient fails repeated SBTs (difficult weaning) or remains unweanable beyond a week or two (prolonged weaning), the priority shifts from performing the trial to diagnosing why the patient cannot sustain spontaneous breathing. The Boles framework reduces the problem to the load-versus-capacity balance, and the causes fall into four groups: [1]

Cardiac

Weaning-induced pulmonary oedema

  • The commonest occult cause — the switch to negative-pressure breathing increases venous return and LV afterload, unmasking diastolic or systolic dysfunction
  • Suspect in the elderly, known heart failure, ischaemic heart disease, rising filling pressures or BNP during the SBT
  • Diagnose with bedside echo, BNP/NT-proBNP, and watching for a rising CVP or new pulmonary oedema on ultrasound/lung auscultation during the SBT
  • Treat with diuresis, afterload reduction, and consideration of NIV as a bridge

Respiratory muscle weakness

ICU-acquired weakness

  • Critical-illness polyneuromyopathy (CIP/CIM), disuse atrophy, electrolyte depletion
  • Diagnosed clinically (MRC sum score <48), reduced MIP, and (definitively) electrophysiology and biopsy
  • Risk factors: sepsis, prolonged immobility, hyperglycaemia, corticosteroids, neuromuscular blockers
  • Prevention and recovery: glucose control, minimise steroids/paralytics, early mobilisation, nutrition, rehabilitation

Residual load

Unresolved lung disease

  • Ongoing pneumonia, pulmonary oedema, COPD with dynamic hyperinflation and auto-PEEP, large pleural effusion, pneumothorax, pulmonary embolism
  • Excessive secretions, bronchospasm, upper-airway obstruction
  • Metabolic load: fever, sepsis, overfeeding (excess CO2 production), acidosis
  • Re-assess the chest: imaging, gas exchange, auto-PEEP measurement

Neurological / metabolic

Drive and chemistry

  • Over-sedation, delirium, encephalopathy (hepatic, uraemic, septic)
  • Electrolyte derangement: hypokalaemia, hypomagnesaemia, hypophosphataemia (respiratory-muscle weakness)
  • Hypothyroidism, neuromuscular disease (myasthenia, GBS)
  • Correct each: lightest effective sedation, treat delirium, replete electrolytes, optimise thyroid

Investigating the difficult-to-wean patient

1

Characterise the failure pattern

Was it respiratory (rising RR, falling SpO2, shallow breathing, high RSBI), cardiac (rising HR, BP, CVP, new oedema, ischaemia on ECG), or neurological (agitation, somnolence, delirium)? The pattern points to the cause.

2

Bedside cardiac assessment

Perform a focused echocardiogram during the SBT: look for LV systolic/diastolic dysfunction, elevated filling pressures, new regional wall motion abnormality. Check BNP/NT-proBNP before and after the SBT. A rising value during the trial supports weaning-induced pulmonary oedema.

3

Respiratory mechanics and load

Measure auto-PEEP (expiratory hold) in COPD, assess compliance and resistance, review the chest X-ray and lung ultrasound for oedema, consolidation, effusion, or pneumothorax. Check the RSBI and consider P0.1.

4

Neuromuscular and metabolic

Examine for weakness (MRC score), measure MIP, check phosphate, magnesium, potassium, calcium, thyroid function, and review the cumulative sedation, steroid, and neuromuscular-blocker exposure. Screen for delirium (CAM-ICU).

5

Treat the cause and re-attempt

Diurese the cardiac patient, replete electrolytes, lighten sedation, treat delirium, mobilise early, drain effusions, relieve obstruction, treat infection. Re-attempt daily SBTs only as the reversible causes are corrected. Do not repeat failing trials mechanically.

Weaning-induced (cardiac) pulmonary oedema — the classic trap

The most exam-relevant and clinically under-recognised cause of difficult weaning is weaning-induced pulmonary oedema, also called weaning-induced cardiac dysfunction or, in COPD, COPD-weaning pulmonary oedema. The mechanism is a haemodynamic consequence of the transition from positive-pressure ventilation back to spontaneous (negative-pressure) breathing: [1]

Why weaning unmasks the heart — the four mechanisms

When the ventilator is withdrawn and the patient resumes negative-pressure breathing, four changes conspire to stress the left ventricle: (1) increased venous return (preload) — intrathoracic pressure falls, raising right and left ventricular filling; (2) increased left-ventricular afterload — the negative intrathoracic pressure of inspiration increases LV transmural pressure, raising the pressure the LV must generate; (3) increased myocardial oxygen demand — from tachycardia, hypertension, and increased wall stress; and (4) ventricular interdependence — the engorged right ventricle shifts the septum leftward, impairing LV filling. In a patient with occult systolic or (especially) diastolic dysfunction, the result is acute pulmonary oedema during the SBT, manifesting as a rising respiratory rate, falling SpO2, crackles, and a rising BNP. The diagnosis is confirmed by a rising CVP/filling pressure or BNP during the trial and new B-lines on lung ultrasound, and the management is diuresis, afterload reduction, and (often) NIV as a bridge.

[1]

This is the answer to the classic fellowship MCQ: a COPD patient who repeatedly fails SBTs, developing tachypnoea and desaturation within minutes, whose cardiac biomarkers rise — the cause is weaning-induced pulmonary oedema from LV dysfunction unmasked by the removal of positive pressure, not bronchospasm or auto-PEEP. [1]

Respiratory muscle weakness — ICU-acquired weakness (ICU-AW)

ICU-acquired weakness (ICU-AW) is a major contributor to prolonged weaning, especially after severe sepsis, ARDS, or prolonged immobility. It encompasses critical-illness polyneuropathy (CIP), critical-illness myopathy (CIM), and their overlap, and produces a flaccid, symmetric, predominantly proximal weakness with preserved sensation (in pure myopathy) that disables the respiratory muscles as much as the limbs. [1]

ICU-AW — recognition and risk

MRC <48
Diagnosis (sum score, max 60)
manual muscle testing, 5 pairs
Sepsis
Top risk factor
plus immobility, steroids, paralytics
CIM/CIP
Electrophysiology
reduced CMAP/CV; biopsy definitive
Mobilise early
Key prevention
glucose control; minimise paralytics

Respiratory-muscle involvement manifests as a weak cough, low tidal volume, a high RSBI, and a low MIP — the patient simply cannot generate the pressures needed to breathe unaided. There is no specific drug treatment; management is prevention and rehabilitation: tight glucose control, minimise corticosteroids and neuromuscular blockers, early mobilisation, adequate nutrition, and a structured rehabilitation programme. Recovery is slow (weeks to months). [1]

Metabolic, electrolyte, and nutritional factors

Respiratory-muscle function is exquisitely sensitive to metabolic derangement. Three electrolytes deserve specific attention in the difficult-to-wean patient: [1]

  • Hypophosphataemia (especially <0.5-0.8 mmol/L) impairs diaphragm contractility and ATP generation; repletion can measurably improve ventilatory capacity.
  • Hypomagnesaemia and hypokalaemia cause generalized and respiratory-muscle weakness; replete both.
  • Hypocalcaemia and acid-base disturbance contribute similarly. [1]

Nutrition cuts both ways: under-nutrition causes respiratory-muscle wasting and weakness, while overfeeding (particularly excess carbohydrate) increases CO2 production and the ventilatory load, worsening weaning. Aim for euglycaemia — both hyper- and hypoglycaemia are harmful. Thyroid disease (hypothyroidism) and adrenal insufficiency should be excluded as reversible causes of weakness and fatigue. [1]

Replete phosphate, magnesium, and potassium before blaming the lungs

In the difficult-to-wean patient, always check and correct phosphate, magnesium, and potassium. Severe hypophosphataemia alone can cause respiratory-muscle failure and is rapidly reversible. Do not overlook the metabolic substrate of the respiratory muscles while chasing the lungs.

[1]

Tracheostomy for prolonged weaning

A tracheostomy is the airway of choice for the patient in prolonged weaning or anticipated prolonged ventilation. It offers real advantages over a translaryngeal tube: improved patient comfort (allowing less sedation), reduced laryngeal damage, easier and safer secretion clearance, oral nutrition and communication, secure airway, and the ability to wean by progressively longer T-piece or tracheostomy-mask off-periods. For many patients it is the gateway to liberation. [1]

The timing of tracheostomy, however, has been a long-standing controversy — early (within the first few days) versus late (after 10-14 days). The definitive answer came from the TracMan trial (Young et al., JAMA 2013), the largest randomised trial of tracheostomy timing: 909 patients predicted to need at least seven more days of ventilation were randomised to early tracheostomy (within four days) or late (after 10 days if still indicated).[6]

TracMan — the key numbers

30.8%
Early 30-day mortality
vs 31.5% late — no difference
0.7%
Absolute risk reduction
95% CI -5.4 to +6.7 — not significant
44.9%
Late group actually got trach
55% never needed one
6.3%
Trach-related complications
no excess in early group

TracMan showed no difference in 30-day mortality, ICU stay, hospital stay, or antibiotic use between early and late tracheostomy. Crucially, only 45 per cent of the late group ever received a tracheostomy — the rest had been extubated or had died — showing that clinicians cannot reliably predict who will need prolonged ventilation. The current practice, supported by TracMan, is to individualise the decision, typically performing a tracheostomy around 7-14 days if prolonged ventilation and weaning remain likely, rather than routinely at day 3-4. [1]

TracMan: early tracheostomy does not save lives

The TracMan trial (JAMA 2013) settled the timing debate: routine early tracheostomy (within four days) confers no mortality or length-of-stay benefit over a wait-and-see approach. Time the tracheostomy to the individual patient — most units perform it around day 7-14 when prolonged weaning is anticipated, balancing comfort, secretion control, and weaning facilitation against the irreversibility of the procedure.[6]

Evidence and landmark trials

2008

ABC (Girard)

Lancet 2008

336 mechanically ventilated pts — paired daily SAT (sedation interruption) + SBT vs usual sedation + daily SBT

Key finding

More ventilator-free days (14.7 vs 11.6), shorter ICU (9.1 vs 12.9 d) and hospital stay, and LOWER 1-year mortality (HR 0.68); NNT 7 to save one life. Self-extubation more common but reintubation identical

Practice change

Established the "wake up and breathe" protocol — pair daily sedation interruption with daily SBT — as the standard of care

1994

Brochard

AJRCCM 1994

109 pts who failed 2-h T-piece — pressure support vs SIMV vs T-piece for weaning

Key finding

PSV superior: fewer weaning failures (23% vs 42-43%) and shorter wean (5.7 vs 8.5-9.9 d); SIMV worst

Practice change

Established pressure support and the comparative framework for weaning methods; foundation for weaning-category definitions

1995

Esteban

NEJM 1995

130 pts who failed initial SBT — once-daily SBT vs multiple SBT vs PSV vs IMV (4-way RCT)

Key finding

Once-daily SBT weaned ~3x faster than IMV (RR 2.83) and ~2x faster than PSV (RR 2.05); multiple daily SBTs equally good

Practice change

Established the once-daily spontaneous breathing trial as the most effective weaning method

2000

Kress (Sedation)

NEJM 2000

128 ventilated pts on continuous sedation — daily sedation interruption vs clinician-directed

Key finding

Shorter ventilation (median 4.9 vs 7.3 d) and ICU stay (6.4 vs 9.9 d); fewer diagnostic tests; no excess self-extubation

Practice change

Daily sedation interruption became a cornerstone — later combined with the SBT in the ABC trial

2003

Ferrer (NIV weaning)

AJRCCM 2003

43 pts (mostly COPD) with persistent weaning failure (3 failed days) — immediate extubation to NIV vs continued invasive weaning

Key finding

Shorter invasive ventilation (9.5 vs 20.1 d), shorter ICU stay, less nosocomial pneumonia (24% vs 59%), fewer tracheostomies, improved survival

Practice change

Extubation to NIV is effective for COPD/hypercapnic patients stuck in weaning failure

2013

TracMan

JAMA 2013

909 pts expected to need >7 d more ventilation — early tracheostomy (≤4 d) vs late (≥10 d)

Key finding

No difference in 30-day mortality (30.8% vs 31.5%), ICU/hospital stay, or antibiotic use; only 45% of the late group ever received a tracheostomy

Practice change

Routine early tracheostomy abandoned; timing individualised (typically day 7-14)

[1]

Prognosis

The outlook is dictated by the weaning category. Simple weaning (about 70 per cent of patients) is usually successful within a day and carries the prognosis of the underlying illness. Difficult weaning roughly doubles the length of stay and carries a moderate mortality. Prolonged weaning (about 10 per cent) consumes the majority of ventilator-days and ICU resources and carries the highest mortality — often 30-50 per cent at one year — driven by the severity of the original illness, comorbidity, and the complications of prolonged ventilation (VAP, ICU-AW, delirium). [1]

Weaning outcomes — the numbers

~70%
Simple weaning
success on first SBT/extubation
80%
SBT-pass extubation success
a passed SBT is strongly predictive
10-20%
Reintubation rate
after apparently successful extubation
NNT 7
ABC trial mortality benefit
paired SAT + SBT saves lives

Reintubation after a successful extubation occurs in 10-20 per cent of patients and is itself associated with a marked increase in mortality, which is why preventing extubation failure (cuff leak testing and prophylactic steroids for PES, prophylactic NIV for high-risk patients) matters as much as passing the SBT. Poor prognostic features include advanced age, severe comorbidity, prolonged ventilation, ICU-AW, persistent delirium, and cardiac failure. Long-term, many survivors of prolonged ventilation have persistent physical and cognitive impairment — the post-intensive-care syndrome (PICS) — and benefit from structured rehabilitation and follow-up. [1]

Clinical pearls

High-yield points for the CICM/FFICM/EDIC exam

  1. Weaning is two decisions, not one: separation from the ventilator (the SBT) and removal of the airway (extubation). A patient can pass an SBT but fail extubation (stridor, secretions, obtundation).[3]
  2. Screen daily for readiness — cause resolved, FiO2 <0.4, PEEP <8, haemodynamically stable, cough/gag intact, manageable secretions, awake and triggering. The screen is the rate-limiting step; test every eligible patient the same day.[1]
  3. The SBT: pressure support 5-7 + PEEP 5, or a T-piece, for 30-120 minutes. A 30-minute trial is as good as 120 minutes. Pass if RR <35, SpO2 >90 per cent, HR <140, no agitation/diaphoresis/distress.[3]
  4. The ABC trial (Girard, Lancet 2008): pair a daily SAT (sedation interruption) with a daily SBT — "wake up and breathe." It cuts ventilation days and ICU stay and saves one life per seven patients (NNT 7). This is the single most important weaning intervention.[1]
  5. Daily sedation interruption (Kress, NEJM 2000) alone reduces ventilation duration (4.9 vs 7.3 days) — the foundation that the ABC trial built on.[4]
  6. Protocol-directed weaning (nurse/RT-driven) beats physician-directed weaning. Brochard (1994) favoured pressure support; Esteban (1995) showed a once-daily SBT weans fastest (3x faster than IMV, 2x faster than PSV).[2][3]
  7. The RSBI (rapid shallow breathing index) = RR ÷ Vt(L); <105 predicts success, >105 predicts failure. Useful but the SBT itself is the best predictor.[3]
  8. Weaning categories: simple (first attempt), difficult (up to three SBTs or up to seven days), prolonged (more than seven days or three failed SBTs). Difficult/prolonged weaning demands a cause hunt.[2]
  9. Cardiac failure is the classic occult cause of difficult weaning — the switch to negative-pressure breathing raises preload and afterload, unmasking LV dysfunction (weaning-induced pulmonary oedema). Suspect it in the elderly, COPD, known heart failure; confirm with echo, rising CVP/BNP during the SBT. Treat with diuresis and afterload reduction.[1]
  10. The cuff leak test: leak <110 mL (or <24 per cent of tidal volume) predicts post-extubation stridor. Give prophylactic steroids (methylprednisolone/dexamethasone) 12-24 h before extubation in high-risk patients. Laryngeal ultrasound is an emerging adjunct.
  11. NIV: prophylactic good, rescue bad. Apply prophylactic NIV immediately after extubation in high-risk patients (COPD, hypercapnia on SBT, cardiac failure) to prevent reintubation (Ferrer 2003). Never use NIV to rescue a patient who has already failed extubation — it delays reintubation and increases mortality.[5]
  12. ICU-acquired weakness (ICU-AW) prolongs weaning: diagnose with MRC sum score <48, low MIP, high RSBI. Prevent and treat with glucose control, minimise steroids/paralytics, early mobilisation, and rehabilitation.[1]
  13. Check phosphate, magnesium, and potassium in every difficult-to-wean patient — hypophosphataemia alone can cause respiratory-muscle failure and is rapidly reversible.
  14. Tracheostomy facilitates prolonged weaning but early tracheostomy does not save lives. The TracMan trial (JAMA 2013) showed no mortality benefit to early (day 4) over late (day 10) placement; individualise the timing, usually around day 7-14.[6]

Red flags

A failing SBT is terminated at once — never push a patient through distress

The SBT is a test, not a treatment. The instant the patient develops a rising respiratory rate (toward 35), falling SpO2, tachycardia, agitation, diaphoresis, or haemodynamic instability, stop the trial and restore comfortable ventilatory support. Continuing a failing trial causes fatigue, worsens gas exchange, and risks cardiac ischaemia and arrest.[3]

Cardiac failure is the commonest occult cause of difficult weaning — look for it

In the patient who repeatedly fails SBTs, especially the elderly, COPD, or known cardiac patient, suspect weaning-induced pulmonary oedema: the removal of positive pressure raises venous return and LV afterload, unmasking occult systolic or diastolic dysfunction. Diagnose with a focused echo, BNP/NT-proBNP (rising during the trial), and lung ultrasound; treat with diuresis, afterload reduction, and consider NIV as a bridge.[1]

Cuff leak <110 mL predicts post-extubation stridor — test and give steroids

In high-risk patients (prolonged intubation, traumatic intubation, female, large tube, repeated intubation), a cuff leak <110 mL or <24 per cent of the tidal volume predicts post-extubation stridor. Give prophylactic steroids (methylprednisolone or dexamethasone) starting 12-24 h before extubation to reduce laryngeal oedema, stridor, and reintubation.

[1]

NIV prevents extubation failure when applied early — but rescue NIV after failure is harmful

Prophylactic NIV applied immediately after extubation to high-risk patients (COPD, hypercapnia on SBT, cardiac failure) reduces reintubation and mortality (Ferrer 2003). Rescue NIV started after a patient has already developed post-extubation respiratory failure increases mortality by delaying necessary reintubation (Esteban 2004). The distinction is timing: prevent, do not rescue.[5]

Routine early tracheostomy does not improve mortality — TracMan (JAMA 2013)

The TracMan trial randomised 909 patients to early (within four days) versus late (after 10 days) tracheostomy and found no difference in 30-day mortality, ICU stay, or antibiotic use. Only 45 per cent of the late group ever needed a tracheostomy. Individualise the timing — typically day 7-14 — rather than routinely performing an early tracheostomy.[6]

Over-sedation and delirium prolong ventilation — use the SAT and the ABCDEF bundle

A patient cannot breathe spontaneously while deeply sedated. Cumulative sedation is a leading, reversible cause of delayed liberation. Use a daily spontaneous awakening trial (sedation interruption) paired with the SBT (the ABC trial), treat delirium (CAM-ICU screening, treat the cause, minimise deliriogenic drugs), and mobilise early. The ABCDEF bundle is the integrated standard.[1][4]

SAQ — Ventilator liberation and difficult weaning

10 minutes · 10 marks

A 68-year-old with COPD has been ventilated for five days after a severe exacerbation. Daily sedation holds are performed. Today FiO2 is 0.35, PEEP 5, he is awake and coughing, secretions are moderate. An SBT on PS 5/PEEP 5 is started; at 20 minutes RR is 38, SpO2 88% on FiO2 0.4, he is diaphoretic and distressed. After return to full support he improves. Echo shows moderate LV systolic impairment; he has a positive fluid balance of 4 L.

[1]

References

  1. [1]Girard TD, Kress JP, Fuchs BD, Thomason JW, Schweickert WD, Pun BT, Taichman DB, Dunn JG, Pohlman AS, Kinniry PA, Jackson JC, Canonico AE, Light RW, Shintani AK, Thompson JL, Gordon SM, Hall JB, Dittus RS, Bernard GR, Ely EW. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial Lancet, 2008.PMID 18191684
  2. [2]Brochard L, Rauss A, Benito S, Conti G, Mancebo J, Rekik N, Gasparetto A, Lemaire F. Comparison of three methods of gradual withdrawal from ventilatory support during weaning from mechanical ventilation Am J Respir Crit Care Med, 1994.PMID 7921460
  3. [3]Esteban A, Frutos F, Tobin MJ, Alía I, Solsona JF, Valverdú I, Fernández R, de la Cal MA, Benito S, Tomás R, et al. A comparison of four methods of weaning patients from mechanical ventilation. Spanish Lung Failure Collaborative Group N Engl J Med, 1995.PMID 7823995
  4. [4]Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation N Engl J Med, 2000.PMID 10816184
  5. [5]Ferrer M, Esquinas A, Arancibia F, Bauer TT, Gonzalez G, Carrillo A, Rodriguez-Roisin R, Torres A. Noninvasive ventilation during persistent weaning failure: a randomized controlled trial Am J Respir Crit Care Med, 2003.PMID 12689847
  6. [6]Young D, Harrison DA, Cuthbertson BH, Rowan K; TracMan Collaborators. Effect of early vs late tracheostomy placement on survival in patients receiving mechanical ventilation: the TracMan randomized trial JAMA, 2013.PMID 23695482